Fortis Malar Hospitals logo

Fortis Malar Hospitals financials: balance sheet, profit and loss, cash flow

BSE: 523696Healthcare ServicesSmall Cap

Fortis Malar Hospitals Limited · Face value ₹10 · Listed Mar 1993
Last close ₹40.57up ₹0.76 (1.91%)

Share price at the BSE close on 28 Oct 2026. Previous close ₹39.81.

28 Oct: open ₹40.00, high ₹41.50, low ₹39.66

52-week range of traded prices to 28 Oct 2026
₹39.00Low, 16 Oct 2026₹68.75High, 29 Oct 2025
Market cap
₹76 Cr2,910th largest listed
P/E
555.81
P/B
2.21
Dividend yield
Nonein the last 12 months
ROE
0.4%
ROCE
−4.6%
Debt to equity
0.00
Volume, BSE
1,842

Fortis Malar Hospitals' financial statements for the 10 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them. It had no borrowings at 31 Mar 2026.

10 years at a glance

₹ crore, years to March.Fortis Malar Hospitals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
1413.1Mar 171493.3Mar 181452.10Mar 19112−8.90Mar 2069−7.90Mar 2186−8.353Mar 2286−1546Mar 2359450Mar 2400.40Mar 250.14.10Mar 26
Peak revenue ₹149 Cr, year to Mar 2018; lowest ₹0.00 Cr, year to Mar 2025A loss in 4 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
8,096.7%−3,083.8%0.6%1.2%−1.7%−2.5%−9.2%8.9%5.3%−2.0%−3,083.8%2.2%2.2%1.4%−7.9%−11.4%−9.6%−18.0%76.8%8,096.7%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue0.1
  2. Employee costs−0.1
  3. Other expenses−1.5
  4. Operating profit−1.6
  5. Depreciation0.0
  6. Other income+6.3
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax4.7
  10. Tax−0.6
  11. Net profit4.1

What the company owns

  • Cash and bank₹25 Cr
  • Plant, investments and other assets₹13 Cr

What pays for it: net worth and liabilities

  • Net worth₹34 Cr
  • Other liabilities₹3 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Fortis Malar Hospitals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 MayJun 2026Twelve monthsFiled 4 Aug
Revenue from operations14114914511269868659000
14014714711576788160222
Materials and goods bought––33211417139000
Employee costs––232218191915000
Other expenses––907243434936222
Operating profit before depreciation12−2−3−685−1−2−2−2
Operating margin0.6%1.2%−1.7%−2.5%−9.2%8.9%5.3%−2.0%–−3,083.8%–
Materials, % of revenue––23.1%19.1%20.3%19.8%14.7%14.9%–0.0%–
Employee costs, % of revenue––16.2%19.3%26.4%21.6%22.6%25.7%–189.4%–
Other expenses, % of revenue––62.4%64.2%62.5%49.7%57.4%61.5%–2,994.3%–
Depreciation and amortisation444131317129000
Operating profit after depreciation−3−2−7−15−19−9−8−11−2−2−2
Other income8810118777362
Finance costs00187764000
Profit before one-off items and tax463−12−18−8−7−8151
One-off items000070058000
Profit before tax463−12−11−8−750151
121−3−3085011
Net profit332−9−8−8−1545040
Other comprehensive income––000000000
Total comprehensive income––2−9−8−9−1645040
Net margin2.2%2.2%1.4%−7.9%−11.4%−9.6%−18.0%76.8%–8,096.7%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
105968980641093034
Share capital1919191919191919
Reserves8778706145911116
0005346000
4436253132673
262564942000
Total assets1511941691611381163738
3913210911254331
112626049841133437
Net debt−7−43−144137−108−18−25
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
−176−721
−1386−2−2−1
−741−101
Receivables10−1000
Inventories001000
Payables−361−3−10
Other working capital−4−11211
Tax paid12−10−531
Capital spending110200
Free cash flow−156−1021
−2880120−290
Cash from financing−7−10−13−11−800
Dividends paid0000800
Shares bought back000000
Shares issued000000
Net change in cash−365−7102−1071
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Fortis Malar Hospitals dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
Earnings per share₹1.67₹1.78₹1.10−₹4.75−₹4.20−₹4.41−₹8.26₹24.18₹0.21₹2.21
Diluted earnings per share₹1.66₹1.77₹1.09−₹4.75−₹4.20−₹4.41−₹8.26₹24.18₹0.21₹2.21
Dividend per share–––––––₹42.50––
Book value per share––₹56.18₹51.40₹47.31₹42.72₹34.21₹58.36₹16.11₹18.31
Dividend payout–––––––175.9%––
Shareholder yield––––0.0%0.0%0.0%0.0%57.9%0.0%
Market cap at the year end (₹ crore)13110910381104108898713878

Ratios

Consolidated, years to March.Fortis Malar Hospitals PE ratio and valuation

RatioMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Filed 18 May
Revenue growth6.1%−3.1%−22.6%−38.1%24.5%−0.3%−31.3%−100.0%–
Operating profit growth94.8%––––−40.6%–––
Net profit growth6.7%−38.1%–––––−99.1%955.5%
Earnings per share growth6.6%−38.2%–––––−99.1%952.4%
–2.0%−8.8%−8.5%−9.8%−21.5%52.2%–12.8%
––−10.8 pts0.3 pts−1.3 pts−11.7 pts73.7 pts––
From the net margin––−12.9 pts−3.8 pts1.3 pts−8.6 pts113.0 pts––
From asset turnover––3.5 pts5.2 pts−2.6 pts−1.9 pts−17.5 pts––
From borrowing––−1.4 pts−1.1 pts0.0 pts−1.2 pts−21.8 pts––
Return on capital employed–−6.5%−15.9%−21.6%−6.8%−6.9%−9.6%−7.1%−4.6%
Cash conversion––––––−16.1%393.9%15.1%
Debt to equity–0.000.000.000.670.720.000.000.00
Receivable days–2412119140–0
Inventory days–18224240320––
Payable days–257324373429584217––
Cash conversion cycle, days–−215−289−320−380−539−217––
Working capital days–156−5511551219−8–63,897
Asset turnover–0.960.650.380.520.580.460.000.00
Assets per rupee of net worth–1.431.711.961.952.071.461.091.15
Sales per rupee of plant–7.011.431.031.511.82–––
Capital spending to depreciation–––0.040.080.000.25––
Plant being built, % of plant in use–0.0%0.1%0.5%0.0%0.0%–––
Interest cover is left blank for the years to Mar 2017, Mar 2018, Mar 2019, Mar 2020, Mar 2021, Mar 2022, Mar 2023, Mar 2024 and Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
11.1%
Measure10 years5 years3 years
Revenue growth, yearly rate–−76.4%−91.6%
Return on equity, average–8.4%32.5%
Return on capital employed, average–−7.0%−7.1%
Operating margin, average−342.6%−767.9%−1,542.9%
Net margin, average903.6%2,036.5%4,086.7%
Asset turnover, average–0.310.16
Debt to equity, average–0.280.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations7−51
Cash from investing100910
Cash from financing−113−910
Capital spending420
Dividends paid80800
Shares bought back000
Shares issued for cash000
Borrowings raised000
Borrowings repaid000

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––4575––
Altman Z-scorePublished threshold 1.81––3.741.731.941.972.2512.4513.8516.48
Beneish M-scorePublished threshold −1.78––––−3.09−3.55−3.20−1.57––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––11.31−14.15−14.45−52.8436.608.21
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––––0.240.00−0.10
Receivables growth less revenue growthOur threshold 0 percentage points–––−38.79−5.80−19.2845.06−68.65––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––15.4658.56−6.55−15.18−69.24––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−3.02−8.70−3.75−1.993.92–−8,051.66
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.210.000.00–––
Effective tax ratePublished threshold 17.16 per cent30.3040.6026.34––––9.3731.0012.45
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––––−0.68−545.40−17.98
A threshold marked as ours has no published figure; it is the line we read the check against.